Mirtazapine Drug Class
Mirtazapine is a tetracyclic antidepressant classified as a noradrenergic and specific serotonergic antidepressant (NaSSA). 1
Chemical Structure and Classification
Mirtazapine has a tetracyclic chemical structure and belongs to the piperazino-azepine group of compounds 1. This distinguishes it from other major antidepressant classes:
- Not a tricyclic antidepressant (TCA) - despite having some structural similarities
- Not a selective serotonin reuptake inhibitor (SSRI)
- Not a serotonin-norepinephrine reuptake inhibitor (SNRI)
Mechanism of Action
The drug works through a unique mechanism that sets it apart from other antidepressant classes 1:
- Antagonizes presynaptic α2-adrenergic receptors (both auto-receptors and heteroreceptors)
- Enhances central noradrenergic and serotonergic activity
- Antagonizes serotonin 5-HT2 and 5-HT3 receptors while having no significant affinity for 5-HT1A and 5-HT1B receptors
- Antagonizes histamine H1 receptors (explaining its sedative effects)
- Antagonizes peripheral α1-adrenergic receptors (explaining orthostatic hypotension risk)
- Minimal anticholinergic activity at muscarinic receptors
Clinical Context
Multiple clinical guidelines consistently refer to mirtazapine as a tetracyclic antidepressant or NaSSA when discussing its use in various conditions 2, 3, 4, 5, 3. The 2008 American College of Physicians guideline specifically categorizes it among second-generation antidepressants but notes its distinct classification 4.
The drug's classification as a NaSSA reflects its dual mechanism of enhancing both noradrenergic and specific serotonergic neurotransmission, which differs fundamentally from SSRIs (which only affect serotonin reuptake) and SNRIs (which affect both serotonin and norepinephrine reuptake but through different mechanisms) 6, 7.